Actemera (Tocilizumab) Infusions

Actemra is a biologic therapy used to treat moderate to severe rheumatoid arthritis in adults and children (such as systemic juvenile idiopathic arthritis-SJIA, and polyarticular juvenile idiopathic arthritis-PJIA).

Generically known as tocilizumab, Actemera infusions can be used in rheumatoid arthritis treatment, helping reduce pain and swelling. Additionally, Actemra may also be used to treat a reaction (Cytokine Release Syndrome-CRS) caused by certain cancer treatments.

Actemra belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. Tocilizumab infusions work by blocking IL-6, a substance made by the body that causes swelling.

Drug manufacturer information for Actemera is available here.

Indication:

  • Moderate to Severe Rheumatoid Arthritis (RA)

  • Systemic Sclerosis-Associate Interstitial Lung Disease (SSc-ILD)

  • Giant Cell Arteritis (GCA)

  • Polyarticular Juvenile Idiopathic Arthritis (PJIA)

  • Systemic Juvenile Idiopathic Arthritis (SJIA)

Actemera Infusion Duration:

Frequency:

  • Every 2-4 weeks